Position in GILD
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$3,247,222,731
+$361,269,774 QoQ
Shares Held
23,299,295
-0.9% QoQ
Ownership
1.88%
of shares outstanding
% of Portfolio
0.26%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 56.00956595467803.ToString("F0")%
Shared 0.ToString("F0")%
None 43.990434045321976.ToString("F0")%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026MORGAN STANLEY holds $57,054,147,722 across 20 Drug Manufacturers - General names. GILD ranks #6 (5.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
15,437,458 | $14,198,910,733 | |
| 2 | JNJ |
Johnson & Johnson
|
44,721,167 | $10,931,642,052 | |
| 3 | ABBV |
AbbVie Inc.
|
38,016,774 | $8,268,268,167 | |
| 4 | MRK |
Merck & Co., Inc.
|
47,632,487 | $5,729,711,852 | |
| 5 | AMGN |
Amgen Inc
|
15,836,058 | $5,571,916,998 | |
| 6 | GILD |
Gilead Sciences, Inc.
This page
|
23,299,295 | $3,247,222,731 | |
| 7 | PFE |
Pfizer Inc
|
92,685,370 | $2,602,605,180 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
29,198,554 | $1,770,892,290 |
All Filings in GILD
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,247,222,731 | 23,299,295 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $2,885,952,957 | 23,512,734 | Shares | Defined | 2026-05-27 | |
| 2025-09-30 | $2,634,560,136 | 23,734,776 | Shares | Defined | 2026-05-27 | |
| 2025-06-30 | $2,531,728,523 | 22,835,109 | Shares | Defined | 2025-08-15 | |
| 2025-03-31 | $2,218,699,799 | 19,800,980 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $1,853,908,655 | 20,070,463 | Shares | Defined | 2025-05-15 | |
| 2024-09-30 | $1,446,119,094 | 17,248,558 | Shares | Defined | 2025-05-14 | |
| 2024-06-30 | $1,326,732,417 | 19,337,304 | Shares | Defined | 2025-05-14 | |
| 2024-03-31 | $1,319,495,023 | 18,013,584 | Shares | Defined | 2024-10-17 | |
| 2023-12-31 | $1,442,117,165 | 17,801,718 | Shares | Defined | 2024-08-16 | |
| 2023-09-30 | $1,267,206,839 | 16,909,619 | Shares | Defined | 2023-11-15 | |
| 2023-06-30 | $1,290,986,072 | 16,750,825 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $1,336,442,918 | 16,107,544 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $1,476,358,151 | 17,196,950 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $951,041,472 | 15,416,461 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,101,863,747 | 17,826,626 | Shares | Defined | 2022-10-27 | |
| 2022-03-31 | $802,878,903 | 13,505,112 | Shares | Defined | 2022-10-27 | |
| 2021-12-31 | $1,134,850,438 | 15,629,396 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $1,075,664,009 | 15,399,628 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $756,762,580 | 10,989,872 | Shares | Defined | 2021-08-23 | |
| 2021-03-31 | $600,251,507 | 9,287,506 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $415,064,160 | 7,124,342 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $380,246,832 | 6,017,516 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $448,433,014 | 5,828,347 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $483,956,838 | 6,473,473 | Shares | Defined | 2020-05-26 | |
| No filing history on record for this holder in this stock. | ||||||